ERIN MCCLUSKEY: Open Payments
NPI 1679764088 · LOYSVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 75 payments from 17 companies in 2025. Trend: 2023 $1,193 · 2024 $1,129 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $254 |
| ABBVIE INC. | 11 | $208 |
| GlaxoSmithKline, LLC. | 10 | $153 |
| Lilly USA, LLC | 9 | $127 |
| PFIZER INC. | 6 | $114 |
| Sumitomo Pharma America, Inc. | 3 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Abbott Laboratories | 2 | $49 |
Products named: Wegovy, QULIPTA, GEMTESA, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, NURTEC ODT, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
